BrazilHealthcare and life sciences2024 – ongoingBrazilian Hospital Services Company (EBSERH)
NoHarm.ai prescription-review pilot at HE-UFPel
HE-UFPel reported that prescribers accepted 72.1% of AI-assisted pharmaceutical recommendations
Problem
Clinical pharmacists needed to identify medication problems in hospital prescriptions. Review required checking doses and interactions against patient information.
Approach
HE-UFPel piloted the integration of NoHarm.ai with the AGHUx hospital system used by EBSERH. Pharmacists checked information displayed by the AI and made recommendations to prescribers. The project recorded AI-assisted interventions from August 2024 to August 2025.
Results
Takeaway
The acceptance rate measured changes made after pharmacist recommendations. It did not establish a reduction in medication injuries.
Categories
- Size
- Large enterprise
- Industry
- Healthcare and life sciences
- Business function
- Production and quality
- Innovation type
- Process innovation
- AI technology
- Predictive analytics and ML
- Adoption
- Partner co-development
- Evidence
- Company's own claim
Sources
Source summaries
Hospital-affiliated researchers described the NoHarm.ai integration pilot and pharmacists' review process. They reported 376 recommendations, including 271 accepted by prescribers, corresponding to 72.1%.
Full details are in the original sources.